Stock screenerAll disclosures →
EDGAR →
PBH
Conviction 15HealthcareScan · Thu, Jun 25, 2026PBH$47.20-0.25%
ResistanceSupportVol 14Insider sell2
Vol MA14 770.59K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price47.20
Change-0.25%
Gap+2.30%
Rel volume1.73×
Avg volume732.5K
Avg $ vol34.37M
SMA 2047.00
SMA 5050.76
SMA 20059.66
Price vs 50-7.02%
Price vs 200-20.89%
MA stackbearish
50/200 cross—
Supertrenddown · 51.28
RSI (14)46
MACD hist0.27
MACD cross—
Stoch %K / %D43 / 39
ADX (14)27
+DI / −DI19 / 18
RSI divergence—
MACD divergence—
ATR %+4.06%
ADR %3.69%
52w high81.74
52w low45.44
From 52w high-42.26%
Above 52w low+3.87%
New 52w highNo
SqueezeOn · 8d
Bollinger width9.15%
%B0.55
Donchian pos50.80%
Donchian high49.81
Donchian low44.51
AVWAP (52w high)60.78
vs AVWAP high-22.34%
AVWAP (52w low)46.96
vs AVWAP low+0.52%
OBV trendFlat
Chaikin MF (20)0.03
Today vs 20d1.73×
Avg vol (14d)770.59K
Avg vol (20d)732.5K
Avg $ vol (20d)34.37M
Market cap2.24B
RS 3m (vs SPY)-35.93%
RS 6m (vs SPY)-31.09%
RS line new highNo
Trend template0/8
Technical rank24.2
1 week+2.30%
1 month-1.71%
3 months-22.79%
6 months-24.70%
1 year-44.25%
YTD-22.90%
P/E11.75
P/B1.18
P/S2.05
P/FCF9.07
EPS3.91
Div yield—
ROE10.08%
ROA5.45%
Debt/Eq0.53
Current3.57
EV/EBITDA9.33
Gross margin54.71%
Net margin17.48%
Rev growth-4.31%
EPS growth-11.33%
Price target72.00
Target upside52.54%
Analyst ratingBuy
Institutional123.39%
Ent. value3.18B
Revenue283.44M
Net income46.7M
Gross profit157.37M
Free cash flow246.45M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out47.37M
Employees890
ListedThu, Feb 10, 2005
Free float46.65M
Float %98.6%
Short interest2.48M
Days to cover3.4d
Short volume71.9%
Squeeze score59 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast$0.89 · 3 est
Last EPS vs est$1.23 vs $1.39
Last surprise-11.5% miss
Setup gradeD
Conviction15 / 100
Pattern quality—
Tech rank24.2 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance49.66
Support43.56
Days since event—
Candle confirm—
News sentiment—
Financials as of Wed, Dec 31, 2025 · quarterly.
Congress activity
Disclosed STOCK Act trades in PBH
No recent disclosed trades by Congress in PBH. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PBH · 10 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Sacco Christine CFO & COO · Common Stock, par value $0.01 per share · 2026-05-02 | Tax | 1.09K | $60K | 2026-05-02 | 2026-05-14 |
Zerillo Jeffrey Senior VP Operations · Common Stock, par value $0.01 per share · 2026-05-11 | Sell | 351 | $18K | 2026-05-11 | 2026-05-12 |
Mekhail Adel EVP, Marketing & Sales · Common Stock, par value $0.01 per share · 2026-05-07 | Tax | 487 | $27K | 2026-05-07 | 2026-05-11 |
Lombardi Ronald M. Chief Executive Officer · Common Stock, par value $0.01 per share · 2026-05-07 | Tax | 2.54K | $139K | 2026-05-07 | 2026-05-11 |
Zerillo Jeffrey Senior VP Operations · Common Stock, par value $0.01 per share · 2026-05-07 | Sell | 305 | $17K | 2026-05-07 | 2026-05-11 |
Sacco Christine CFO & COO · Common Stock, par value $0.01 per share · 2026-05-07 | Tax | 991 | $54K | 2026-05-07 | 2026-05-11 |
Zerillo Jeffrey Senior VP Operations · Common Stock, par value $0.01 per share · 2026-05-07 | Tax | 351 | $19K | 2026-05-07 | 2026-05-11 |
Lombardi Ronald M. Chief Executive Officer · Common Stock, par value $0.01 per share · 2026-05-05 | Tax | 2.2K | $122K | 2026-05-05 | 2026-05-07 |
Zerillo Jeffrey Senior VP Operations · Common Stock, par value $0.01 per share · 2026-05-05 | Sell | 1.21K | $66K | 2026-05-05 | 2026-05-07 |
Zerillo Jeffrey Senior VP Operations · Common Stock, par value $0.01 per share · 2026-05-05 | Tax | 307 | $17K | 2026-05-05 | 2026-05-07 |
SEC filings
EDGAR filings in PBH · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.